CAD1.60
4.76% yesterday
Toronto, Nov 15, 10:00 pm CET
ISIN
CA42249X1006
Symbol
AIDX

Healwell AI Target price 2024 - Analyst rating & recommendation

Healwell AI Classifications & Recommendation:

Buy
100%

Healwell AI Price Target

Target Price CAD3.81
Price CAD1.60
Potential
Number of Estimates 8
8 Analysts have issued a price target Healwell AI 2025 . The average Healwell AI target price is CAD3.81. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 8 Analysts recommend Healwell AI to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Healwell AI stock has an average upside potential 2025 of . Most analysts recommend the Healwell AI stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million CAD 7.32 38.12
86.25% 420.80%
EBITDA Margin -153.14% -35.94%
463.64% 76.53%
Net Margin -1,246.37% -113.13%
852.09% 90.92%

8 Analysts have issued a sales forecast Healwell AI 2024 . The average Healwell AI sales estimate is

CAD38.1m
Unlock
. This is
48.45% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CAD38.9m 51.48%
Unlock
, the lowest is
CAD37.6m 46.42%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 CAD7.3m 86.25%
2024
CAD38.1m 420.80%
Unlock
2025
CAD70.6m 85.28%
Unlock
2026
CAD83.9m 18.76%
Unlock
2027
CAD100m 19.26%
Unlock
2028
CAD120m 19.56%
Unlock

8 Analysts have issued an Healwell AI EBITDA forecast 2024. The average Healwell AI EBITDA estimate is

CAD-13.7m
Unlock
. This is
23.59% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CAD-12.9m 28.05%
Unlock
, the lowest is
CAD-14.7m 18.28%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 CAD-11.2m 22.48%
2024
CAD-13.7m 22.21%
Unlock
2025
CAD-7.3m 46.47%
Unlock
2026
CAD-967k 86.81%
Unlock
2027
CAD2.5m 358.22%
Unlock
2028
CAD20.1m 703.55%
Unlock

EBITDA Margin

2023 -153.14% 463.64%
2024
-35.94% 76.53%
Unlock
2025
-10.38% 71.12%
Unlock
2026
-1.15% 88.92%
Unlock
2027
2.50% 317.39%
Unlock
2028
16.78% 571.20%
Unlock

1 Analyst has issued a net profit forecast Healwell AI 2024 . The average Healwell AI net profit estimate is

CAD-43.1m
Unlock
. This is
36.85% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CAD-43.1m 36.85%
Unlock
, the lowest is
CAD-43.1m 36.85%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 CAD-91.2m 30.95%
2024
CAD-43.1m 52.73%
Unlock
2025
CAD-19.9m 53.84%
Unlock
2026
CAD-5.0m 74.99%
Unlock

Net Margin

2023 -1,246.37% 852.09%
2024
-113.13% 90.92%
Unlock
2025
-28.18% 75.09%
Unlock
2026
-5.93% 78.96%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share CAD -0.55 -0.26
30.95% 52.73%
P/E negative
EV/Sales 7.35

1 Analysts have issued a Healwell AI forecast for earnings per share. The average Healwell AI <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

CAD-0.26
Unlock
. This is
36.84% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
CAD-0.26 36.84%
Unlock
, the lowest is
CAD-0.26 36.84%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 CAD-0.55 30.95%
2024
CAD-0.26 52.73%
Unlock
2025
CAD-0.12 53.85%
Unlock
2026
CAD-0.03 75.00%
Unlock

P/E ratio

Current -8.23 580.17%
2024
-6.15 25.27%
Unlock
2025
-13.33 116.75%
Unlock
2026
-53.33 300.08%
Unlock

Based on analysts' sales estimates for 2024, the Healwell AI stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.91 527.01%
2024
7.35 32.63%
Unlock
2025
3.97 46.03%
Unlock
2026
3.34 15.80%
Unlock
2027
2.80 16.15%
Unlock
2028
2.34 16.36%
Unlock

P/S ratio

Current 10.48 769.39%
2024
7.06 32.64%
Unlock
2025
3.81 46.03%
Unlock
2026
3.21 15.80%
Unlock
2027
2.69 16.15%
Unlock
2028
2.25 16.36%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today